Following this spike, switching rates declined but remained elevated through September 2025 at 1.6% on average before returning to an average baseline level of 0.6% between October 2025 and February 2026
Whether you choose PlushCare, Ro, or a compounded GLP-1 program through PlexusDx, combining baseline biomarker testing with genetic predisposition insight supports a more personalized conversation with your provider
SIRT1
At Next Health, we look for optimal levels and value the incremental 1% improvements in your data over time
Louis Zollo, a pharmacy practice leader at the consultancy Segal, told Reuters that even with unit costs falling, " the patient population keeps growing
These medications work by blocking enzymes called cyclooxygenases (COX-1 and COX-2), which play a role in producing prostaglandins